Combining APR-246 and HDAC-Inhibitors: A Novel Targeted Treatment Option for Neuroblastoma.

ROS TP53 histone deacetylases pediatric tumors of the nervous system precision medicine response prediction biomarker small molecule inhibitors

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
05 Sep 2021
Historique:
received: 19 08 2021
accepted: 30 08 2021
entrez: 10 9 2021
pubmed: 11 9 2021
medline: 11 9 2021
Statut: epublish

Résumé

APR-246 (Eprenetapopt/PRIMA-1

Identifiants

pubmed: 34503286
pii: cancers13174476
doi: 10.3390/cancers13174476
pmc: PMC8431508
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Mildred Scheel Doctoral Scholarship
ID : 70113124
Organisme : SFB 1389-UNITE Glioblastoma
ID : Work Package A02
Organisme : H.W. & J. Hector Foundation
ID : M91
Organisme : Ministry of Rural Affairs and Consumer Protection Baden-Wuerttemberg
ID : ID 4781

Références

Oncogene. 2005 May 12;24(21):3484-91
pubmed: 15735745
Arch Toxicol. 2018 Aug;92(8):2649-2664
pubmed: 29947893
Biochemistry (Mosc). 2021 Mar;86(3):262-274
pubmed: 33838628
Oxid Med Cell Longev. 2016;2016:7053451
pubmed: 28058088
Database (Oxford). 2017 Jan 1;2017:
pubmed: 29220450
Eur J Cancer. 2016 Sep;65:91-101
pubmed: 27479119
Science. 2018 Dec 7;362(6419):1165-1170
pubmed: 30523111
J Clin Oncol. 2012 Oct 10;30(29):3633-9
pubmed: 22965953
Biomed J. 2014 May-Jun;37(3):99-105
pubmed: 24923566
Nat Rev Drug Discov. 2014 Sep;13(9):673-91
pubmed: 25131830
Nature. 2012 Mar 28;483(7391):603-7
pubmed: 22460905
Am J Cancer Res. 2021 Mar 01;11(3):729-745
pubmed: 33791150
J Clin Oncol. 2009 Jan 10;27(2):298-303
pubmed: 19047290
Nat Med. 2002 Mar;8(3):282-8
pubmed: 11875500
J Clin Oncol. 2009 Jan 10;27(2):289-97
pubmed: 19047291
Int J Oncol. 2021 Mar;58(3):312-330
pubmed: 33650649
Blood. 2003 Mar 1;101(5):2001-7
pubmed: 12393499
Clin Cancer Res. 2009 Jan 1;15(1):91-9
pubmed: 19118036
Proc Natl Acad Sci U S A. 2013 Jul 9;110(28):E2592-601
pubmed: 23801752
Nat Genet. 2017 Aug;49(8):1261-1266
pubmed: 28650485
Cancer Cell. 2019 Nov 11;36(5):528-544.e10
pubmed: 31631026
Cold Spring Harb Perspect Med. 2016 Aug 01;6(8):
pubmed: 27329033
J Clin Invest. 2014 Jan;124(1):30-9
pubmed: 24382387
EMBO Rep. 2019 Dec 5;20(12):e48375
pubmed: 31668005
Oncotarget. 2016 Dec 13;7(50):83017-83030
pubmed: 27806324
Curr Med Chem. 2019;26(40):7212-7280
pubmed: 29852860
Autophagy. 2013 Dec;9(12):2163-5
pubmed: 24145760
Nat Chem Biol. 2016 Feb;12(2):109-16
pubmed: 26656090
Br J Cancer. 2013 Nov 12;109(10):2696-704
pubmed: 24129240
J Vis Exp. 2017 Mar 7;(121):
pubmed: 28362421
Nat Commun. 2019 Apr 4;10(1):1530
pubmed: 30948783
Front Biosci. 2005 May 01;10:1881-96
pubmed: 15769673
Nature. 2017 Sep 7;549(7670):96-100
pubmed: 28854174
Cell. 2018 May 31;173(6):1413-1425.e14
pubmed: 29754815
Cell. 2013 Aug 29;154(5):1151-1161
pubmed: 23993102
Int J Mol Sci. 2020 Jan 13;21(2):
pubmed: 31940975
Nat Commun. 2017 Mar 28;8:14844
pubmed: 28348409
Am J Pathol. 2001 Jun;158(6):2067-77
pubmed: 11395384
Cell Death Dis. 2013 Oct 24;4:e881
pubmed: 24157875
Cell Growth Differ. 1998 Jul;9(7):545-55
pubmed: 9690622
Proc Natl Acad Sci U S A. 1995 May 9;92(10):4407-11
pubmed: 7753819
Haematologica. 2020 Jan;105(1):170-181
pubmed: 31073076
Acta Neuropathol Commun. 2015 Apr 03;3:22
pubmed: 25853389
Nat Rev Cancer. 2003 Mar;3(3):203-16
pubmed: 12612655
Cells. 2015 Apr 23;4(2):135-68
pubmed: 25915736
Sci Rep. 2017 Aug 22;7(1):9041
pubmed: 28831158
Curr Pharm Des. 2009;15(4):436-47
pubmed: 19199971
Sci Rep. 2018 Jul 3;8(1):10039
pubmed: 29968769
J Exp Clin Cancer Res. 2019 Feb 12;38(1):69
pubmed: 30755224
J Mol Diagn. 2005 Feb;7(1):89-96
pubmed: 15681479
Cancer Cell. 2009 May 5;15(5):376-88
pubmed: 19411067
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Cancer Res. 2014 May 1;74(9):2604-16
pubmed: 24419085
Pharmaceuticals (Basel). 2020 Oct 27;13(11):
pubmed: 33121173
Cell Death Dis. 2018 Apr 18;9(5):439
pubmed: 29670092
Nucleic Acids Res. 2020 Jul 2;48(W1):W488-W493
pubmed: 32246720
Cancer Discov. 2015 Nov;5(11):1210-23
pubmed: 26482930
Clin Cancer Res. 2010 Jun 15;16(12):3240-52
pubmed: 20413433
Klin Padiatr. 2012 Oct;224(6):398-403
pubmed: 22915450
Int J Mol Sci. 2020 Sep 16;21(18):
pubmed: 32948088
Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8424-9
pubmed: 12826609
Blood Cancer J. 2016 Jul 15;6(7):e447
pubmed: 27421096
Eur J Cancer. 2017 Sep;83:258-265
pubmed: 28756138

Auteurs

Michael Müller (M)

Hopp Children's Cancer Center Heidelberg (KiTZ), 69120 Heidelberg, Germany.
Clinical Cooperation Unit Pediatric Oncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Faculty of Medicine, Heidelberg University, 69120 Heidelberg, Germany.

Lisa Rösch (L)

Hopp Children's Cancer Center Heidelberg (KiTZ), 69120 Heidelberg, Germany.
Clinical Cooperation Unit Pediatric Oncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Faculty of Biosciences, Heidelberg University, 69120 Heidelberg, Germany.

Sara Najafi (S)

Hopp Children's Cancer Center Heidelberg (KiTZ), 69120 Heidelberg, Germany.
Clinical Cooperation Unit Pediatric Oncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Department of Pediatric Oncology, Hematology and Immunology, University of Heidelberg Medical Center, 69120 Heidelberg, Germany.

Charlotte Gatzweiler (C)

Hopp Children's Cancer Center Heidelberg (KiTZ), 69120 Heidelberg, Germany.
Clinical Cooperation Unit Pediatric Oncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Faculty of Medicine, Heidelberg University, 69120 Heidelberg, Germany.

Johannes Ridinger (J)

Hopp Children's Cancer Center Heidelberg (KiTZ), 69120 Heidelberg, Germany.
Clinical Cooperation Unit Pediatric Oncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.

Xenia F Gerloff (XF)

Hopp Children's Cancer Center Heidelberg (KiTZ), 69120 Heidelberg, Germany.
Clinical Cooperation Unit Pediatric Oncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Department of Pediatric Oncology, Hematology and Immunology, University of Heidelberg Medical Center, 69120 Heidelberg, Germany.

David T W Jones (DTW)

Hopp Children's Cancer Center Heidelberg (KiTZ), 69120 Heidelberg, Germany.
Pediatric Glioma Research Group, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), 69120 Heidelberg, Germany.

Jochen Baßler (J)

Biochemistry Center, Heidelberg University, 69120 Heidelberg, Germany.

Sina Kreth (S)

Hopp Children's Cancer Center Heidelberg (KiTZ), 69120 Heidelberg, Germany.
Neuroblastoma Genomics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.

Sabine Stainczyk (S)

Hopp Children's Cancer Center Heidelberg (KiTZ), 69120 Heidelberg, Germany.
Neuroblastoma Genomics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.

Karen Frese (K)

Institute for Cardiomyopathies Heidelberg, Heidelberg University, 69120 Heidelberg, Germany.

Benjamin Meder (B)

Institute for Cardiomyopathies Heidelberg, Heidelberg University, 69120 Heidelberg, Germany.
Genome Technology Center, Stanford University, Stanford, CA 94304, USA.

Frank Westermann (F)

Hopp Children's Cancer Center Heidelberg (KiTZ), 69120 Heidelberg, Germany.
Neuroblastoma Genomics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.

Till Milde (T)

Hopp Children's Cancer Center Heidelberg (KiTZ), 69120 Heidelberg, Germany.
Clinical Cooperation Unit Pediatric Oncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Department of Pediatric Oncology, Hematology and Immunology, University of Heidelberg Medical Center, 69120 Heidelberg, Germany.

Heike Peterziel (H)

Hopp Children's Cancer Center Heidelberg (KiTZ), 69120 Heidelberg, Germany.
Clinical Cooperation Unit Pediatric Oncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.

Olaf Witt (O)

Hopp Children's Cancer Center Heidelberg (KiTZ), 69120 Heidelberg, Germany.
Clinical Cooperation Unit Pediatric Oncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Department of Pediatric Oncology, Hematology and Immunology, University of Heidelberg Medical Center, 69120 Heidelberg, Germany.

Ina Oehme (I)

Hopp Children's Cancer Center Heidelberg (KiTZ), 69120 Heidelberg, Germany.
Clinical Cooperation Unit Pediatric Oncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.

Classifications MeSH